119 related articles for article (PubMed ID: 26235176)
1. How can we identify new biomarkers for patients with for lung metastasectomy in colorectal cancer.
Renaud S; Falcoz PE
Future Oncol; 2015; 11(15):2109-11. PubMed ID: 26235176
[No Abstract] [Full Text] [Related]
2. KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.
Renaud S; Romain B; Falcoz PE; Olland A; Santelmo N; Brigand C; Rohr S; Guenot D; Massard G
Br J Cancer; 2015 Feb; 112(4):720-8. PubMed ID: 25688918
[TBL] [Abstract][Full Text] [Related]
3. Perioperative bevacizumab improves survival following lung metastasectomy for colorectal cancer in patients harbouring v-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue exon 2 codon 12 mutations†.
Renaud S; Schaeffer M; Falcoz PE; Seitlinger J; Romain B; Voegeli AC; Legrain M; Reeb J; Santelmo N; Rohr S; Brigand C; Olland A; Guenot D; Massard G
Eur J Cardiothorac Surg; 2017 Feb; 51(2):255-262. PubMed ID: 28186237
[TBL] [Abstract][Full Text] [Related]
4. Reply: Comment on 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colo-rectal cancer'.
Renaud S; Falcoz PE; Romain B; Olland A; Santelmo N; Brigand C; Rohr S; Guenot D; Massard G
Br J Cancer; 2015 Dec; 113(11):1637-8. PubMed ID: 26372702
[No Abstract] [Full Text] [Related]
5. Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis.
Mammana M; Bergamo F; Procaccio L; Schiavon M; Loupakis F; Lonardi S; Manai C; Schirripa M; Fassan M; Dei Tos AP; Calabrese F; Rea F; Zagonel V
Tumori; 2021 Feb; 107(1):46-54. PubMed ID: 32597321
[TBL] [Abstract][Full Text] [Related]
6. Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy.
Cardillo G; Mokhles S; Williams N; Macbeth F; Russell C; Treasure T
Br J Cancer; 2015 Dec; 113(11):1636. PubMed ID: 26372699
[No Abstract] [Full Text] [Related]
7. Mutation status and surgical selection.
Margonis GA; Kreis ME; Wolfgang CL; Weiss MJ
J Surg Oncol; 2019 Apr; 119(5):616-622. PubMed ID: 30779134
[TBL] [Abstract][Full Text] [Related]
8. An Unusual Combination: KRAS and BRAF Co-mutated Metastatic Colorectal Cancer.
Epperla N; George B
J Gastrointest Cancer; 2016 Jun; 47(2):206-9. PubMed ID: 26018827
[No Abstract] [Full Text] [Related]
9. Positive association of PIK3CA mutation with KRAS mutation but not BRAF mutation in colorectal cancer suggests co-selection is gene specific but not pathway specific.
Susanti S; Fadhil W; Murtaza S; Hassall JC; Ebili HO; Oniscu A; Ilyas M
J Clin Pathol; 2019 Mar; 72(3):263-264. PubMed ID: 30361395
[No Abstract] [Full Text] [Related]
10. New Guideline on Managing Colorectal Cancer.
Cancer Discov; 2017 Apr; 7(4):OF2. PubMed ID: 28249840
[TBL] [Abstract][Full Text] [Related]
11. KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer.
Renaud S; Guerrera F; Seitlinger J; Costardi L; Schaeffer M; Romain B; Mossetti C; Claire-Voegeli A; Filosso PL; Legrain M; Ruffini E; Falcoz PE; Oliaro A; Massard G
Oncotarget; 2017 Jan; 8(2):2514-2524. PubMed ID: 27911859
[TBL] [Abstract][Full Text] [Related]
12. Identification of high-risk Dukes B colorectal cancer by microRNA expression profiling: a preliminary study.
Aslam MI; Venkatesh J; Jameson JS; West K; Pringle JH; Singh B
Colorectal Dis; 2015 Jul; 17(7):578-88. PubMed ID: 25557290
[TBL] [Abstract][Full Text] [Related]
13. Anatomical Resections Improve Survival Following Lung Metastasectomy of Colorectal Cancer Harboring KRAS Mutations.
Renaud S; Seitlinger J; Lawati YA; Guerrera F; Falcoz PE; Massard G; Ferri L; Spicer J
Ann Surg; 2019 Dec; 270(6):1170-1177. PubMed ID: 29781848
[TBL] [Abstract][Full Text] [Related]
14. The unfulfilled promise of molecular diagnosis in colorectal cancer.
Golfinopoulos V; Hendlisz A
Curr Opin Oncol; 2010 Jul; 22(4):362-3. PubMed ID: 20473163
[No Abstract] [Full Text] [Related]
15. High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort.
Sorbye H; Dragomir A; Sundström M; Pfeiffer P; Thunberg U; Bergfors M; Aasebø K; Eide GE; Ponten F; Qvortrup C; Glimelius B
PLoS One; 2015; 10(6):e0131046. PubMed ID: 26121270
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of KRAS mutation in patients undergoing pulmonary metastasectomy for colorectal cancer: A systematic review and meta-analysis.
Huang J; Zang Q; Wen Y; Pan Z; Yao Z; Huang M; Huang J; Chen J; Wang R
Crit Rev Oncol Hematol; 2021 Apr; 160():103308. PubMed ID: 33753248
[TBL] [Abstract][Full Text] [Related]
17. Systematic review: brain metastases from colorectal cancer--Incidence and patient characteristics.
Christensen TD; Spindler KL; Palshof JA; Nielsen DL
BMC Cancer; 2016 Apr; 16():260. PubMed ID: 27037031
[TBL] [Abstract][Full Text] [Related]
18. Schistosoma infection, KRAS mutation status, and prognosis of colorectal cancer.
Li X; Liu H; Huang B; Yang M; Fan J; Zhang J; Weng M; Yan Z; Liu L; Cai K; Nie X; Chang X
Chin Med J (Engl); 2024 Jan; 137(2):235-237. PubMed ID: 37920960
[No Abstract] [Full Text] [Related]
19. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K
PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997
[TBL] [Abstract][Full Text] [Related]
20. [Colorectal serrated lesions: current insight on their role in colorectal carcinogenesis].
Mäkinen M
Duodecim; 2010; 126(17):2002-11. PubMed ID: 21053517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
